|
Compound Information
|
| ID |
392 |
| TrivialName |
notoginsenoside-LY |
| Type |
C17-side chain varied |
| MF |
C₄₁H₆₈O₁₂ |
| MolecularWeight |
752.983 |
| IUPACName |
NT |
| m/z |
NT |
| Retention Time |
NT |
| CCS |
NT |
| Adducts |
NT |
| Isomeric SMILES |
CC1(C)[C@@H](O[H])CC[C@@]2(C)C1C([H])C[C@]3(C)C2C[C@@H]4C5[C@@]3(C)CCC5[C@@](C)(O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]7[C@H](O)[C@@H](O)[C@H](CO)O7)O6)CC(/C=C(C)/C)O4 |
| Canonical SMILES |
CC(C)=CC1CC(C)(OC2OC(COC3OC(CO)C(O)C3O)C(O)C(O)C2O)C2CCC3(C)C2C(CC2C4(C)CCC(O)C(C)(C)C4CCC23C)O1 |
| Source |
PN |
| Functions |
anti-diabetic, anti-obesity, inhibitory activity against PTP1B (diabetes) |
| Year |
2014 |
| References |
Li et al. (2014)
|
| Structure |
|
